technologies than any other system currently on the market.
Ventana develops, manufactures, and markets instrument/reagent systems that automate slide preparation and staining in clinical histology and drug discovery laboratories worldwide. Ventana's clinical systems are important tools used in the diagnosis and treatment of cancer and infectious diseases. Philipp Novales Li, +1 925 866 2579, orCorporate Investor Relations, Mr. InSite(TM) HER 2/Neu (CB11) Monoclonal AntibodyGeoPharma, Inc. (GORX) Announces Dismissal Of Class Action Litigation Relating To Mucotrol (TM)
, a technology leader in molecular pathology, provides systems for complete automation of cell and tissue testing. offers a broad range of reagents, detection kits, antibodies, probes, special stains, tissue microarrays, automated staining and imaging systems to streamline and standardize cellular and molecular diagnostics. The automated systems are designed for high throughput at a low cost of ownership, providing ease of Adidas Hat Gold Logo
Judge Raner C. District Court for the District of Arizona issued the Markman Ruling. Patent No. 6,352,861 (the '861 Patent). Ventana had alleged that 's automated staining instruments infringe the dispensing claims of the '861 Patent. Ventana asserted that any automated staining device that uses bar codes to coordinate reagent dispensing onto samples infringes the '861 claims. disagreed, maintaining that its automated staining systems, the OptiMax(R) Plus and i6000(TM) Systems, used in major histopathology labs worldwide, do not infringe because they dispense reagents differently from the dispensing method required by the '861 Patent.
About Laboratories, Inc.
Specifically, contended that Ventana's patent claims apply only to competitors using bar coding in conjunction with instruments that dispense reagent directly from the reagent container onto a slide. Direct dispensing requires positioning the reagent dispenser over the sample, and applying the reagent directly from the dispenser onto the sample below it. By contrast, the automated staining systems dispense reagent indirectly. 's automated staining systems dispense reagent by means of an intervening reagent transfer device, a robotic XYZ arm holding a micropipette. The micropipette aspirates or "sips" reagent from the reagent bottle, then moves over to and above the tissue sample, and applies the reagent to the sample. This indirect dispensing procedure is known as "sip and spit" dispensing.
TriPath Imaging Inc. (TPTH) Receives FDA 510(k) Clearance For Estrogen Receptor And Progesterone Receptor Applications For Ventana Image Analysis SystemBill Would Permit DNA Collection From All Those Arrested
SAN RAMON, Calif., Oct. 4 /PRNewswire/ has received a favorable ruling in its patent infringement litigation against Ventana Medical Systems . The ruling, known Nike Cap With Silver Tick as a Markman Ruling, limits the Nike Hat Winter
use and maximum flexibility for clinical diagnostics, life science research, and drug discovery. , Accelerating the Pace of Predictive Medicine.
, Inc. Files Second Patent Infringement Lawsuit Against Ventana Medical Systems, Inc. (VMSI)FDA Is Considering Requiring Microchips Be Placed In Medicine Bottles, To Outwit Counterfeiters
The ruling in favor of enhances the already robust environment for 's bar coded automated staining systems, not only the OptiMax(R) Plus and i6000(TM) Systems, but also the recently launched Xmatrx(TM) Automated Staining System, which is capable of performing almost all slide based cell and tissue tests.
scope of Ventana's patent for automated staining.
1 Obtains Favorable Patent Ruling Against 2
and Ventana have agreed that due to this ruling, the Court should now enter Summary Judgment of Non Infringement in favor of .
Krishan L. The Judge's ruling clearly strengthens 's position in the in vitro diagnostics market. This victory now allows to focus on launching our exciting new platform, the Xmatrx(TM) System." The Xmatrx(TM) is 's latest instrument product offer that automates the entire slide processing for IHC, SS, ISH and FISH from microtome to microscope. The Xmatrx(TM) System automates more steps and more Nike Hat Black And White
The Trial Court agreed with , limiting the meaning of the term "dispensing," as used in Ventana's '861 Patent, to "direct dispensing" and to exclude 's "sip and spit dispensing" method.
About Ventana Medical Systems, Inc.
New Era Dallas Cowboys
Louis Vuitton Belt Ladies
Ferragamo Belt Amazon
New Era Caps Snapback
New York Giants Hat
Nike Hats For Womens
Gucci Belt Dragon
New Era Houston Oilers
New Era Caps Yankees
Nike Hat Visor
Gucci Belt Flowers
Adidas Hat Camo
Adidas Cap Asos
Louis Vuitton Belt Amazon